▲ Peaking
Business
Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 win
Amgen reports positive phase 3 trial results for its Horizon-acquired autoimmune drug dazodalibep in treating Sjögren's disease.
Sjögren's Disease
1 trends tracked about this subject — the full history, oldest to newest below.